Abstract
Due to the characteristics unique to monoclonal antibodies (MAbs) and other biotech products, non-human primates (NHP) are often assumed to be the only relevant species to evaluate safety and efficacy of MAbs. However, the scientific value of NHP in MAb development has never been adequately established, and has been debated
... read more